Giant Biogene Holding Co., Ltd. (2367.HK) HKSE
28.90
-0.58(-1.97%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Giant Biogene Holding Co., Ltd.
Sector
Consumer Defensive
Industry
Household & Personal Products
Employees
1758
First IPO Date
November 04, 2022
Key Executives
| Name | Title | Pay | Year Born |
| Jianya Yan | Chief Executive Officer & Executive Chairman of the Board | 880,188 | 1966 |
| Yubo Yan | Chief Product Officer, Joint Company Secretary & Executive Director | 419,247 | 1996 |
| Huijuan Zhang | Chief Financial Officer & Executive Director | 1.14M | 1987 |
| Juan Fang | Senior Vice President & Executive Director | 1.15M | 1974 |
| Juan Ye | Senior Vice President & Executive Director | 1.15M | 1972 |
| Zhiguang Duan | Senior Vice President | 0 | 1982 |
| Yajuan Yan | Senior Vice President | 0 | 1970 |
| Nelly Au-Yeung | Joint Company Secretary | 0 | N/A |
| Wing Yan Yuen FCIS | Joint Company Secretary | 0 | 1970 |
| Daidi Fan | Chief Scientific Officer | 0 | 1967 |
Description
Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People's Republic of China. It also manufactures rare ginsenosides technology-based functional foods; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional foods primarily under the Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi'an, the People's Republic of China.
